Rite Aid Joins Pay-For-Delay MDL Over Generic Niaspan

Law360, New York (May 7, 2015, 6:47 PM EDT) -- A Pennsylvania federal judge folded Rite Aid Corp.’s pay-for-delay suit against AbbVie Inc. and Teva Pharmaceuticals Industries Ltd. over Niaspan generics into related multidistrict litigation pending in the same court on Wednesday, marking the 19th antitrust action in the matter.

The drugstore chain's suit now joins actions by four other direct purchasers of the cholesterol drug claiming, along with 14 end-payors, that AbbVie and Teva reaped millions for illegally delaying the entry of Niaspan generics into the market as part of a collusion with the drug’s maker, Kos Pharmaceuticals.

Rite Aid’s suit, filed April 14, says that while the first of multiple...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS